On-Demand Upstream Manufacturing Webinars
-
Break The Cell Therapy Manufacturing Bottleneck With Day-0 Transduction, Day-3 Harvest
10/14/2025
Discover the potential of T1 cell-derived nanoparticles (CDNPs) to accelerate T-cell activation. See how CDNPs’ unique mechanism of mimicking physiological immune stimulation positions them for broad use.
-
Cell Bank And Scale Up Strategies For MSC And Exosome Manufacturing
10/9/2025
Discover how effective cell banking and scale-up strategies can reduce risk and cost in advanced therapy manufacturing. Learn practical ways to meet increasing cell and exosome quantity needs.
-
Genetically Modified MSCs For The Treatment Of GvHD
9/30/2025
Discover how genetically engineered MSCs are significantly advancing GvHD treatment. Learn about preclinical success with CXCR4-IL10-MSCs and the process for scaling up their GMP production.
-
Effective Supply Chain And QC Testing Through Collaborative Partnerships
9/30/2025
Explore how cross-functional teams streamline cell therapy manufacturing and release for Phase 1 trials to meet patient timelines and ensure safe delivery of personalized treatments.
-
It's Never Too Late To Intensify: Upstream Process Intensification
9/21/2025
Explore how early upstream intensification, flexible facility design, and smart technology choices can reduce costs, improve scalability, and support sustainability in low-volume protein therapy production.
-
Cell Cycle Mapping In Tumors With Advanced Technologies
9/2/2025
Discover how spatial profiling and advanced imaging tools are transforming drug discovery, featuring Wayne Stallaert’s lab’s work on cell cycle mapping and biomarker insights in cancer research.
-
Scaling Plasmid DNA Production: A Proven Strategy For Higher Yields
8/27/2025
Learn how an agile manufacturing partner scaled their plasmid DNA production and achieved higher yields by optimizing their media selection and fermentation processes.
-
N-1 Perfusion Strategies For Commercial-Ready Biologics
8/27/2025
Learn how an approach with modular N-1 perfusion strategies shortens seed train timelines and reduces facility strain — enabling upstream processes that scale efficiently and reliably for commercial manufacturing.
-
Unlock Viral Vector Yield And Efficiency With Upstream Intensification
8/26/2025
Streamline viral vector manufacturing with perfusion technologies that reduce costs and improve scalability. Discover how a tangential flow depth filtration system enhances yield and quality.
-
Next-Gen Disease Models And Cell Therapeutics: Innovations In AI, Omics And Collaboration
8/20/2025
Learn how to leverage AI, omics integration, and collaborative research to build more physiologically relevant disease models and accelerate the development of next-gen cell therapies.